Going beyond HRR mutations: A deep-learning approach on HRD detection in ovarian cancer

Name: Going beyond HRR mutations: A deep-learning approach on HRD detection in ovarian cancer
Start: 2026-11-09
End: 2026-11-09

Starts: November 9, 2026
Ends: November 9, 2026
Format: Online
Location: VIRTUAL

About This Event

Homologous recombination deficiency (HRD) is an important prognostic and predictive biomarker in ovarian cancer. It is assessed by combining information from homologous recombination repair (HRR) gene mutations, the “cause” of HRD, with a measure of genomic scarring, the “effect” of HRD. However, this approach can be complex and challenging.